Dormosedan (detomidine hydrochloride) Gel is indicated for sedation and restraint in horses. Each mL of Dormosedan Gel contains 7.6 mg detomidine hydrochloride. Dormosedan Gel helps produce sedation when gel is administered sublingually at 0.018 per lb. Gel must be placed under horses tongue and is not meant to be swallowed.
Possible Side Effects
Horses treated with Dormosedan exhibit hypertension. Piloerection (hair standing up), sweating, salivation, and slight muscle tremors are frequently seen after administration. Partial transient penis prolapse may be seen. Partial AV and SA blocks may occur with decreased heart and respiratory rates. Incoordination or staggering is usually seen only during the first 3-5 minutes after administration, until animals have secured a firm footing.
Because of continued lowering of the head during sedation, mucus discharges from the nose and, occasionally, edema of the head and face may be seen. Holding the head in a slightly elevated position generally prevents these effects.
Use as directed by your veterinarian. Dormosedan Gel must be placed beneath the tongue of the horse and is not meant to be swallowed. Impermeable gloves must be used during drug administration and during procedures that require contact with the horse’s mouth.
Store at controlled room temperature 15°-30°C (59°-86°F) in the absence of light.
Prescription items are NON-RETURNABLE and NON-REFUNDABLE.